Processa Pharmaceuticals, Inc.

Pages

Processa Pharmaceuticals, Inc.

$PCSA

Search Table
Pages

Trade Date Insider Title Buy or Sell Quantity Security Type Price Proceeds Transaction Conviction Position Quantity Position Value Positon Conviction SEC Link Nature of Ownership
2020-10-01Patrick LinChief Business - Strategy OffBuy31,250Common Stock$2.10-$65,625.00  56.66    [ Very High ]399,737$839,447.70  724.82   [Very High]Form 4-
2020-10-01James H StankerChief Financial OfficerBuy6,000Common Stock$2.10-$12,600.00  10.88    [ Very High ]47,248$99,220.80  85.67    [Very High]Form 4-
2020-10-02James E Besser-Buy30,000Common Shares$4.04-$121,200.00  22.05    [ Very High ]405,000$1,636,200.00  297.71   [Very High]Form 4-
2021-02-18James E Besser-Sell5,000Common Stock, $0.01 par value$11.35$56,750.00  4.73     [ Very High ]1,120,000$12,712,000.00  1,060.00 [Very High]Form 4-
2021-02-19James E Besser-Sell3,000Common Stock, $0.01 par value$11.20$33,600.00  2.84     [ Very High ]1,117,000$12,510,400.00  1,057.16 [Very High]Form 4-
2021-02-22James E Besser-Sell20,929Common Stock, $0.01 par value$11.56$241,939.24  19.81    [ Very High ]1,096,071$12,670,580.76  1,037.36 [Very High]Form 4-